Artwork

Content provided by [email protected] and TTP plc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] and TTP plc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

mRNA: What did Covid teach us about drug development and distribution?

38:05
 
Share
 

Manage episode 377546672 series 2994360
Content provided by [email protected] and TTP plc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] and TTP plc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The Covid vaccination campaign demonstrated the effectiveness of mRNA-based treatments, so what else is this technology capable of? How can we improve our manufacturing and distribution to ensure treatments are available to those who need them most?

To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.

What is mRNA and what is the importance of mRNA treatments?
Messenger ribonucleic acid, or mRNA for short, is a crucial molecule in the process of making proteins in our bodies. Proteins are essential for the structure, function, and regulation of the cells, tissues, and organs in our bodies.

mRNA treatments, also known as mRNA therapeutics, are a type of medical technology that uses synthetic mRNA to treat or prevent various diseases and medical conditions. Vaccines are one of the most well-known examples of mRNA treatments. These treatments are a relatively new and exciting area of medicine with the potential to revolutionize how we approach healthcare.

This Week's Guests

David Sokolowski
David Sokolowski is the Global Workflow Manager for the Nucleic Acid Therapeutics business unit within Cytiva. Cytiva is a global life sciences leader dedicated to helping customers discover and commercialise the next generation of therapeutics. David has been closely monitoring the RNA field and its evolving applications and manufacturing technologies.

Dan Peer
Dan Peer is a Professor at Tel Aviv University and the Director of the Laboratory of Precision Nanomedicine at Tel Aviv. Dan has been actively engaging in nanomedicine for the past 20 years and is also the university's Vice President for Research and Development. Dan is at the forefront of mRNA research and shares his insight on the rapid expansion of mRNA applications.

  continue reading

26 episodes

Artwork
iconShare
 
Manage episode 377546672 series 2994360
Content provided by [email protected] and TTP plc. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] and TTP plc or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

The Covid vaccination campaign demonstrated the effectiveness of mRNA-based treatments, so what else is this technology capable of? How can we improve our manufacturing and distribution to ensure treatments are available to those who need them most?

To find out, join us on Invent: Life Sciences, a podcast brought to you by technology and product development company TTP.

What is mRNA and what is the importance of mRNA treatments?
Messenger ribonucleic acid, or mRNA for short, is a crucial molecule in the process of making proteins in our bodies. Proteins are essential for the structure, function, and regulation of the cells, tissues, and organs in our bodies.

mRNA treatments, also known as mRNA therapeutics, are a type of medical technology that uses synthetic mRNA to treat or prevent various diseases and medical conditions. Vaccines are one of the most well-known examples of mRNA treatments. These treatments are a relatively new and exciting area of medicine with the potential to revolutionize how we approach healthcare.

This Week's Guests

David Sokolowski
David Sokolowski is the Global Workflow Manager for the Nucleic Acid Therapeutics business unit within Cytiva. Cytiva is a global life sciences leader dedicated to helping customers discover and commercialise the next generation of therapeutics. David has been closely monitoring the RNA field and its evolving applications and manufacturing technologies.

Dan Peer
Dan Peer is a Professor at Tel Aviv University and the Director of the Laboratory of Precision Nanomedicine at Tel Aviv. Dan has been actively engaging in nanomedicine for the past 20 years and is also the university's Vice President for Research and Development. Dan is at the forefront of mRNA research and shares his insight on the rapid expansion of mRNA applications.

  continue reading

26 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play